Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

被引：0
|
作者：
Mikihiro Kusama
Tadashi Nomizu
Kenjiro Aogi
Masataka Yoshimoto
Noboru Horikoshi
Toshio Tabei
Shinzaburo Noguchi
Shigeto Miura
Norio Yoshimura
Morihiko Kimura
Kazushige Toyama
Eisei Shin
机构：
[1] Tokyo Medical University,
[2] Hoshi General Hospital,undefined
[3] National Hospital Shikoku Cancer Center,undefined
[4] Cancer Institute Hospital,undefined
[5] Japanese Foundation for Cancer Research,undefined
[6] Saitama Prefectural Cancer Center,undefined
[7] Osaka University,undefined
[8] Aichi Prefecture Cancer Center,undefined
[9] Kyoto Prefectural University,undefined
[10] Gunma Prefecture Cancer Center,undefined
[11] Shizuoka Prefecture General Hospital,undefined
[12] National Osaka Hospital,undefined
[13] Sinjyuku Breast Center Kusama Clinic,undefined
[14] International University of Health and Welfare,undefined
[15] Mita Hospital,undefined
[16] Juntendo University School of Medicine,undefined
[17] Kamiiida Daiichi General Hospital,undefined
[18] Ohta General Hospital,undefined
[19] Shizuoka Health Management Center,undefined
[20] Iseikai Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Capecitabine; Breast cancer; Advanced; Metastatic; Efficacy; Safety; Four-week (Japanese) regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 240
页数：7
相关论文
共 50 条
  • [21] Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer
    Taguchi, Tetsuya
    Nakayama, Takahiro
    Masuda, Norikazu
    Yoshidome, Katsuhide
    Akagi, Kenzou
    Nishida, Yukihiro
    Yoshikawa, Yukinobu
    Ogino, Nobuo
    Abe, Chigusa
    Sakamoto, Junichi
    Noguchi, Shinzaburo
    CHEMOTHERAPY, 2010, 56 (02) : 166 - 170
  • [22] Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer
    Burris, Howard A., III
    Jones, Suzanne F.
    Shipley, Dianna
    Meluch, Anthony A.
    Greco, F. Anthony
    Barton, John H.
    Yardley, Denise A.
    Hainsworth, John D.
    CANCER INVESTIGATION, 2010, 28 (04) : 408 - 412
  • [23] CAPECITABINE AND GEMCITABINE IN METASTATIC BREAST CANCER: A PHASE I-II STUDY
    Giannessi, P. G.
    Di Marsico, R.
    Martella, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [24] Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
    N Batista
    G Perez-Manga
    M Constenla
    A Ruiz
    F Carabantes
    J Castellanos
    M Gonzalez Barón
    K Villman
    M Söderberg
    J Ahlgren
    J Casinello
    P Regueiro
    A Murias
    British Journal of Cancer, 2004, 90 : 1740 - 1746
  • [25] Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
    Batista, N
    Perez-Manga, G
    Constenla, M
    Ruiz, A
    Carabantes, F
    Castellanos, J
    Barón, MG
    Villman, K
    Söderberg, M
    Ahlgren, J
    Casinello, J
    Regueiro, P
    Murias, A
    BRITISH JOURNAL OF CANCER, 2004, 90 (09) : 1740 - 1746
  • [26] Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Fumoleau, P
    Largillier, R
    Clippe, C
    Dièras, V
    Orfeuvre, H
    Lesimple, T
    Culine, S
    Audhuy, B
    Serin, D
    Curé, H
    Vuillemin, E
    Morère, JF
    Montestruc, F
    Mouri, Z
    Namer, M
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) : 536 - 542
  • [27] A pilot phase II study of capecitabine in advanced or recurrent breast cancer.
    Saeki T.
    Kimura T.
    Toi M.
    Taguchi T.
    Breast Cancer, 2006, 13 (1) : 49 - 57
  • [28] Weekly docetaxel in pretreated metastatic breast cancer: A phase I/II study
    Adami, F
    Aitini, F
    Cavazzini, G
    Cantore, M
    Rabbi, C
    Pari, F
    Zamagni, D
    Sorio, M
    Smerieri, F
    ANNALS OF ONCOLOGY, 2000, 11 : 35 - 35
  • [29] Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: A phase II study
    Nishimura, R
    Ogawa, T
    Kato, M
    Tanaka, M
    Hamada, Y
    Shibata, T
    Ishikawa, E
    Koga, T
    Mitsuyama, S
    Tamura, K
    CHEMOTHERAPY, 2005, 51 (2-3) : 126 - 131
  • [30] Randomized, phase II trial comparing continuous versus intermittent capecitabine monotherapy for metastatic breast cancer (MBC)
    Martin, M.
    Calvo, L.
    Martinez, N.
    Ramos, M.
    Munoz, M.
    Zamora, P.
    Hernando, B.
    Casado, A.
    Garcia-Saenz, J. A.
    Puente, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345